1. Non-invasive whole-body imaging of immune checkpoints using PET-labeled small molecules as predictive biomarker for response to therapy

   Wazynska, M., Butera, R., de Bruyn, M., Domling, A. S. S., Elsinga, P. H. & Nijman, H. W., Oct-2019, In : European Journal of Nuclear Medicine and Molecular Imaging. 46, SUPPL 1, p. S739-S740 2 p.

   Research output: Contribution to journal › Meeting Abstract › Academic

2. Pd-Catalyzed de Novo Assembly of Diversely Substituted Indole-Fused Polyheterocycles

   Wang, Q., Osipyan, A., Konstantinidou, M., Butera, R., Mgimpatsang, K. C., Shishkina, S. V. & Dömling, A., 20-Sep-2019, In : The Journal of Organic Chemistry. 84, 18, p. 12148-12156 9 p.

   Research output: Contribution to journal › Article › Academic › peer-review

3. Development of the Inhibitors that Target the PD-1/PD-L1 Interaction-A Brief Look at Progress on Small Molecules, Peptides and Macrocycles

   Guzik, K., Tomala, M., Muszak, D., Konieczny, M., Hec, A., Błaszkiewicz, U., Pustuła, M., Butera, R., Dömling, A. & Holak, T. A., 30-May-2019, In : Molecules. 24, 11, 30 p., 2071.

   Research output: Contribution to journal › Review article › Academic › peer-review

4. A patent review on PD-1/PD-L1 antagonists: small molecules, peptides, and macrocycles (2015-2018)

   Shaabani, S., Huizinga, H. P. S., Butera, R., Kouchi, A., Guzik, K., Magiera-Mularz, K., Holak, T. A. & Domling, A., 2018, In : Expert Opinion on Therapeutic Patents. 28, 9, p. 665-678 14 p.

   Research output: Contribution to journal › Article › Academic › peer-review

View all (4) »